BlackRock Institutional Trust Company, N.A. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$8,072,000
-33.0%
3,391,717
+3.4%
0.00%
-50.0%
Q3 2016$12,044,000
+66.2%
3,281,709
+1.0%
0.00%
+100.0%
Q2 2016$7,245,000
+8.0%
3,248,858
+0.7%
0.00%0.0%
Q1 2016$6,709,000
-33.5%
3,225,374
-3.1%
0.00%
-50.0%
Q4 2015$10,089,000
+25.1%
3,329,793
+2.0%
0.00%
+100.0%
Q3 2015$8,064,000
-26.6%
3,264,747
-4.7%
0.00%
-50.0%
Q2 2015$10,993,000
-5.8%
3,424,517
+4.8%
0.00%0.0%
Q1 2015$11,671,000
+57.4%
3,269,130
+0.1%
0.00%
+100.0%
Q4 2014$7,413,000
+15.1%
3,265,419
-1.7%
0.00%0.0%
Q3 2014$6,441,000
-46.4%
3,320,223
+0.2%
0.00%
-50.0%
Q2 2014$12,028,000
-2.6%
3,313,446
+4.1%
0.00%0.0%
Q1 2014$12,355,000
+42.7%
3,184,370
+4.8%
0.00%0.0%
Q4 2013$8,658,000
-10.3%
3,037,933
+12.7%
0.00%0.0%
Q3 2013$9,653,000
-1.1%
2,696,481
-7.7%
0.00%0.0%
Q2 2013$9,760,0002,922,1060.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders